Sound Income Strategies, LLC - ZYNERBA PHARMACEUTICALS INC ownership

ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 63 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.0%.

Quarter-by-quarter ownership
Sound Income Strategies, LLC ownership history of ZYNERBA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$445
+290.4%
3500.0%0.00%
Q2 2023$114
-24.5%
3500.0%0.00%
Q1 2023$151
-18.8%
3500.0%0.00%
Q4 2022$1863500.0%0.00%
Q3 2022$03500.0%0.00%
Q2 2022$0
-100.0%
3500.0%0.00%
Q1 2022$1,0000.0%3500.0%0.00%
Q4 2021$1,0000.0%3500.0%0.00%
Q3 2021$1,000
-50.0%
3500.0%0.00%
Q2 2021$2,000
-99.9%
3500.0%0.00%
Q1 2021$1,628,000
+162700.0%
3500.0%0.00%
Q4 2020$1,0000.0%3500.0%0.00%
Q3 2020$1,0000.0%3500.0%0.00%
Q2 2020$1,0000.0%3500.0%0.00%
Q1 2020$1,000
-50.0%
3500.0%0.00%
Q4 2019$2,000
-33.3%
3500.0%0.00%
-100.0%
Q3 2019$3,000
-40.0%
3500.0%0.00%
-50.0%
Q2 2019$5,000
+150.0%
3500.0%0.00%
+100.0%
Q1 2019$2,0003500.00%
Other shareholders
ZYNERBA PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Ground Swell Capital, LLC 25,445$19,0000.05%
ETF MANAGERS GROUP, LLC 2,258,970$1,654,0000.05%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 116,780$85,0000.02%
GSA CAPITAL PARTNERS LLP 131,036$96,0000.01%
Bernardo Wealth Planning LLC 30,469$20,0000.01%
PCG Wealth Advisors, LLC 15,200$12,0000.00%
Penserra Capital Management LLC 212,298$155,0000.00%
ZEKE CAPITAL ADVISORS, LLC 49,700$36,0000.00%
King Wealth Management Group 16,000$12,0000.00%
Vident Investment Advisory, LLC 105,398$77,0000.00%
View complete list of ZYNERBA PHARMACEUTICALS INC shareholders